Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123


Hyperkalemia in patients with chronic renal failure.

Seliger SL.

Nephrol Dial Transplant. 2019 Dec 1;34(Supplement_3):iii12-iii18. doi: 10.1093/ndt/gfz231.


Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.

Pandey A, Patel KV, Vongpatanasin W, Ayers C, Berry JD, Mentz RJ, Blaha MJ, McEvoy JW, Muntner P, Vaduganathan M, Correa A, Butler J, Shimbo D, Nambi V, deFilippi C, Seliger SL, Ballantyne CM, Selvin E, de Lemos JA, Joshi PH.

Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.043337. [Epub ahead of print] No abstract available.


Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients.

Chen H, Watnick T, Hong SN, Daly B, Li Y, Seliger SL.

BMC Nephrol. 2019 Oct 25;20(1):386. doi: 10.1186/s12882-019-1555-z.


Text preprocessing for improving hypoglycemia detection from clinical notes - A case study of patients with diabetes.

Zhou L, Siddiqui T, Seliger SL, Blumenthal JB, Kang Y, Doerfler R, Fink JC.

Int J Med Inform. 2019 Sep;129:374-380. doi: 10.1016/j.ijmedinf.2019.06.020. Epub 2019 Jul 9.


Cardiac function assessed by myocardial deformation in adult polycystic kidney disease patients.

Lassen MCH, Qasim AN, Biering-Sørensen T, Reeh JLT, Watnick T, Seliger SL, Chen H, Sawan MA, Nguyen D, Li Y, Hong SN, Park M.

BMC Nephrol. 2019 Aug 16;20(1):324. doi: 10.1186/s12882-019-1500-1.


Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.

Lamprea-Montealegre JA, Zelnick LR, Shlipak MG, Floyd JS, Anderson AH, He J, Christenson R, Seliger SL, Soliman EZ, Deo R, Ky B, Feldman HI, Kusek JW, deFilippi CR, Wolf MS, Shafi T, Go AS, Bansal N; CRIC Study Investigators.

J Am Heart Assoc. 2019 Aug 6;8(15):e012200. doi: 10.1161/JAHA.119.012200. Epub 2019 Aug 5.


Disparities in Diffuse Cortical White Matter Integrity Between Socioeconomic Groups.

Shaked D, Leibel DK, Katzel LI, Davatzikos C, Gullapalli RP, Seliger SL, Erus G, Evans MK, Zonderman AB, Waldstein SR.

Front Hum Neurosci. 2019 Jun 12;13:198. doi: 10.3389/fnhum.2019.00198. eCollection 2019.


Sociodemographic disparities in corticolimbic structures.

Shaked D, Millman ZB, Moody DLB, Rosenberger WF, Shao H, Katzel LI, Davatzikos C, Gullapalli RP, Seliger SL, Erus G, Evans MK, Zonderman AB, Waldstein SR.

PLoS One. 2019 May 9;14(5):e0216338. doi: 10.1371/journal.pone.0216338. eCollection 2019.


Commentary on Risks of Living Kidney Donation: Current State of Knowledge on Core Outcomes Important to Donors.

Kestenbaum BR, Seliger SL.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):609-610. doi: 10.2215/CJN.01650219. Epub 2019 Mar 11. No abstract available.


Commentary on "Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in CKD".

Kestenbaum BR, Seliger SL.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):137-138. doi: 10.2215/CJN.13431118. Epub 2018 Dec 28. No abstract available.


Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study.

Pandey A, Keshvani N, Ayers C, Correa A, Drazner MH, Lewis A, Rodriguez CJ, Hall ME, Fox ER, Mentz RJ, deFilippi C, Seliger SL, Ballantyne CM, Neeland IJ, de Lemos JA, Berry JD.

JAMA Cardiol. 2019 Jan 1;4(1):51-58. doi: 10.1001/jamacardio.2018.4300.


Lifetime discrimination burden, racial discrimination, and subclinical cerebrovascular disease among African Americans.

Beatty Moody DL, Taylor AD, Leibel DK, Al-Najjar E, Katzel LI, Davatzikos C, Gullapalli RP, Seliger SL, Kouo T, Erus G, Rosenberger WF, Evans MK, Zonderman AB, Waldstein SR.

Health Psychol. 2019 Jan;38(1):63-74. doi: 10.1037/hea0000638. Epub 2018 Nov 26.


Dorsolateral prefrontal cortex volume as a mediator between socioeconomic status and executive function.

Shaked D, Katzel LI, Seliger SL, Gullapalli RP, Davatzikos C, Erus G, Evans MK, Zonderman AB, Waldstein SR.

Neuropsychology. 2018 Nov;32(8):985-995. doi: 10.1037/neu0000484. Epub 2018 Sep 13.


Commentary on Complications of Immunosuppressive Treatments for Glomerulonephritis.

Kestenbaum BR, Seliger SL.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1276-1277. doi: 10.2215/CJN.07610618. Epub 2018 Jul 24. No abstract available.


A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease.

Seliger SL, Abebe KZ, Hallows KR, Miskulin DC, Perrone RD, Watnick T, Bae KT.

Am J Nephrol. 2018;47(5):352-360. doi: 10.1159/000488807. Epub 2018 May 18.


"Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).

Peters MN, Seliger SL, Christenson RH, Hong-Zohlman SN, Daniels LB, Lima JAC, de Lemos JA, Neeland IJ, deFilippi CR.

J Am Heart Assoc. 2018 Feb 8;7(4). pii: e006619. doi: 10.1161/JAHA.117.006619.


Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.

Mindikoglu AL, Opekun AR, Mitch WE, Magder LS, Christenson RH, Dowling TC, Weir MR, Seliger SL, Howell CD, Raufman JP, Rana A, Goss JA, Khaderi SA, Vierling JM.

Dig Dis Sci. 2018 Mar;63(3):665-675. doi: 10.1007/s10620-017-4897-z. Epub 2018 Feb 1.


Inflammation and Trajectory of Renal Function in Community-Dwelling Older Adults.

Salimi S, Shardell MD, Seliger SL, Bandinelli S, Guralnik JM, Ferrucci L.

J Am Geriatr Soc. 2018 Apr;66(4):804-811. doi: 10.1111/jgs.15268. Epub 2018 Jan 23.


Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis.

Mindikoglu AL, Opekun AR, Putluri N, Devaraj S, Sheikh-Hamad D, Vierling JM, Goss JA, Rana A, Sood GK, Jalal PK, Inker LA, Mohney RP, Tighiouart H, Christenson RH, Dowling TC, Weir MR, Seliger SL, Hutson WR, Howell CD, Raufman JP, Magder LS, Coarfa C.

Transl Res. 2018 May;195:25-47. doi: 10.1016/j.trsl.2017.12.002. Epub 2017 Dec 12.


Commentary on Lessons from CKD-Related Genetic Association Studies-Moving Forward.

Kestenbaum B, Seliger SL.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):153-154. doi: 10.2215/CJN.12421117. Epub 2017 Dec 14. No abstract available.


Sedentary Behavior and Subclinical Cardiac Injury: Results From the Dallas Heart Study.

Harrington JL, Ayers C, Berry JD, Omland T, Pandey A, Seliger SL, Ballantyne CM, Kulinski J, deFilippi CR, de Lemos JA.

Circulation. 2017 Oct 10;136(15):1451-1453. doi: 10.1161/CIRCULATIONAHA.117.029493. No abstract available.


Commentary on "Effectiveness of Treatment Modalities on Kidney Stone Recurrence".

Seliger SL, Kestenbaum BR.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1709-1710. doi: 10.2215/CJN.07780717. Epub 2017 Aug 22. No abstract available.


Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts.

de Lemos JA, Ayers CR, Levine BD, deFilippi CR, Wang TJ, Hundley WG, Berry JD, Seliger SL, McGuire DK, Ouyang P, Drazner MH, Budoff M, Greenland P, Ballantyne CM, Khera A.

Circulation. 2017 May 30;135(22):2119-2132. doi: 10.1161/CIRCULATIONAHA.117.027272. Epub 2017 Mar 30.


A Multibiomarker Approach to Heart Failure Prognostication: A Work in Progress.

deFilippi CR, Seliger SL.

JACC Heart Fail. 2017 Apr;5(4):265-267. doi: 10.1016/j.jchf.2017.02.019. No abstract available.


High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).

Seliger SL, Hong SN, Christenson RH, Kronmal R, Daniels LB, Lima JAC, de Lemos JA, Bertoni A, deFilippi CR.

Circulation. 2017 Apr 18;135(16):1494-1505. doi: 10.1161/CIRCULATIONAHA.116.025505. Epub 2017 Feb 3.


Commentary on Symptom Management of the Patient with CKD: The Role of Dialysis.

Kestenbaum B, Seliger SL.

Clin J Am Soc Nephrol. 2017 Apr 3;12(4):694-695. doi: 10.2215/CJN.11781116. Epub 2017 Feb 1. No abstract available.


Loss of executive function after dialysis initiation in adults with chronic kidney disease.

Kurella Tamura M, Vittinghoff E, Hsu CY, Tam K, Seliger SL, Sozio S, Fischer M, Chen J, Lustigova E, Strauss L, Deo R, Go AS, Yaffe K; CRIC Study Investigators.

Kidney Int. 2017 Apr;91(4):948-953. doi: 10.1016/j.kint.2016.11.015. Epub 2017 Jan 27.


Obesity and Survival With Heart Failure: Still a Paradox.

deFilippi CR, Seliger SL.

JACC Heart Fail. 2017 Jan;5(1):64-66. doi: 10.1016/j.jchf.2016.11.011. No abstract available.


Commentary on Biomarkers for Early Detection and Prognosis of AKI.

Kestenbaum B, Seliger SL.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):174-175. doi: 10.2215/CJN.07910716. Epub 2016 Nov 8. No abstract available.


Introducing the Evidence-Based Nephrology Series.

Kestenbaum B, Seliger SL.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2061. No abstract available.


Differential Associations of Socioeconomic Status With Global Brain Volumes and White Matter Lesions in African American and White Adults: the HANDLS SCAN Study.

Waldstein SR, Dore GA, Davatzikos C, Katzel LI, Gullapalli R, Seliger SL, Kouo T, Rosenberger WF, Erus G, Evans MK, Zonderman AB.

Psychosom Med. 2017 Apr;79(3):327-335. doi: 10.1097/PSY.0000000000000408.


Commentary on Pharmacotherapy of Hypertension in Patients on Chronic Dialysis.

Seliger SL, Kestenbaum B.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2076-2077. Epub 2016 Oct 24. No abstract available.


Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade.

Palevsky PM, Zhang JH, Seliger SL, Emanuele N, Fried LF; VA NEPHRON-D Study.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1944-1953. Epub 2016 Sep 27.


Impact of moderate physical activity on the longitudinal trajectory of a cardiac specific biomarker of injury: Results from a randomized pilot study of exercise intervention.

deFilippi CR, de Lemos JA, Newman AB, Guralnik JM, Christenson RH, Pahor M, Church T, Espeland M, Krithevsky SB, Stafford R, Seliger SL; LIFE Study Group.

Am Heart J. 2016 Sep;179:151-6. doi: 10.1016/j.ahj.2016.07.001. Epub 2016 Jul 12.


Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population.

Parikh RH, Seliger SL, Christenson R, Gottdiener JS, Psaty BM, deFilippi CR.

J Am Heart Assoc. 2016 Aug 1;5(8). pii: e003188. doi: 10.1161/JAHA.115.003188.


Microvascular endothelial dysfunction is associated with albuminuria and CKD in older adults.

Seliger SL, Salimi S, Pierre V, Giffuni J, Katzel L, Parsa A.

BMC Nephrol. 2016 Jul 13;17(1):82. doi: 10.1186/s12882-016-0303-x.


Anemia and risk for cognitive decline in chronic kidney disease.

Kurella Tamura M, Vittinghoff E, Yang J, Go AS, Seliger SL, Kusek JW, Lash J, Cohen DL, Simon J, Batuman V, Ordonez J, Makos G, Yaffe K.

BMC Nephrol. 2016 Jan 28;17:13. doi: 10.1186/s12882-016-0226-6.


Frailty and Cognitive Impairment in ESRD: Brain-Body Connections.

Seliger SL.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2104-6. doi: 10.2215/CJN.11321015. Epub 2015 Nov 16. No abstract available.


Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis.

Parikh RH, Seliger SL, de Lemos J, Nambi V, Christenson R, Ayers C, Sun W, Gottdiener JS, Kuller LH, Ballantyne C, deFilippi CR.

Clin Chem. 2015 Dec;61(12):1524-31. doi: 10.1373/clinchem.2015.244160. Epub 2015 Oct 27.


Renal function and long-term decline in cognitive function: the Baltimore Longitudinal Study of Aging.

Seliger SL, Wendell CR, Waldstein SR, Ferrucci L, Zonderman AB.

Am J Nephrol. 2015;41(4-5):305-12. doi: 10.1159/000430922. Epub 2015 Jun 6.


Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines.

Mindikoglu AL, Dowling TC, Magder LS, Christenson RH, Weir MR, Seliger SL, Hutson WR, Howell CD.

Clin Gastroenterol Hepatol. 2016 Apr;14(4):624-632.e2. doi: 10.1016/j.cgh.2015.06.021. Epub 2015 Jun 29.


Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort Study.

Sandsmark DK, Messé SR, Zhang X, Roy J, Nessel L, Lee Hamm L, He J, Horwitz EJ, Jaar BG, Kallem RR, Kusek JW, Mohler ER 3rd, Porter A, Seliger SL, Sozio SM, Townsend RR, Feldman HI, Kasner SE; CRIC Study Investigators.

Stroke. 2015 Aug;46(8):2075-80. doi: 10.1161/STROKEAHA.115.009861. Epub 2015 Jun 30.


Improved cognitive performance after a single dialysis session: where do we go from here?

Elias MF, Seliger SL, Torres RV.

Nephrol Dial Transplant. 2015 Sep;30(9):1414-7. doi: 10.1093/ndt/gfv263. Epub 2015 Jun 23. No abstract available.


Natriuretic peptide and cardiovascular risk: is it about "U"?

deFilippi CR, Seliger SL.

J Am Heart Assoc. 2015 May 21;4(5). pii: 002086. doi: 10.1161/JAHA.115.002086. No abstract available.


Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).

Seliger SL, de Lemos J, Neeland IJ, Christenson R, Gottdiener J, Drazner MH, Berry J, Sorkin J, deFilippi C.

JACC Heart Fail. 2015 Jun;3(6):445-455. doi: 10.1016/j.jchf.2014.12.018. Epub 2015 May 14.


Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction.

Parikh RH, Seliger SL, deFilippi CR.

Clin Biochem. 2015 Mar;48(4-5):247-53. doi: 10.1016/j.clinbiochem.2015.01.004. Epub 2015 Jan 22. Review.


Periodontal disease, renal dysfunction and heightened leukocytosis.

Salimi S, Ng N, Seliger SL, Parsa A.

Nephron Clin Pract. 2014;128(1-2):107-14. doi: 10.1159/000366445. Epub 2014 Nov 8.


Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.

Rahman M, Xie D, Feldman HI, Go AS, He J, Kusek JW, Lash J, Miller ER 3rd, Ojo A, Pan Q, Seliger SL, Steigerwalt S, Townsend RR; CRIC Study Investigators.

Am J Nephrol. 2014;40(5):399-407. doi: 10.1159/000368915. Epub 2014 Nov 11.


Complete inhibition of the renin-angiotensin-aldosterone system; where do we stand?

Chen SS, Seliger SL, Fried LF.

Curr Opin Nephrol Hypertens. 2014 Sep;23(5):449-55. doi: 10.1097/MNH.0000000000000043. Review.


A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements.

Mindikoglu AL, Dowling TC, Wong-You-Cheong JJ, Christenson RH, Magder LS, Hutson WR, Seliger SL, Weir MR.

Am J Nephrol. 2014;39(6):543-52. doi: 10.1159/000363584. Epub 2014 Jun 17.

Supplemental Content

Loading ...
Support Center